Literature DB >> 10406618

Ophthalmic abnormalities in patients with cutaneous T-cell lymphoma.

B E Cook1, G B Bartley, M R Pittelkow.   

Abstract

OBJECTIVE: To determine the frequency of ophthalmic abnormalities in patients with cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome) and T-cell lymphoma involving the skin and to describe the clinical course of the disease with selected examples.
DESIGN: Retrospective, clinic-based, cross-sectional study. PARTICIPANTS: A computerized diagnostic retrieval system was used to identify all patients with T-cell lymphoma involving the skin who were examined at the Mayo Clinic (Rochester, Minnesota) between January 1, 1976 and December 31, 1990. The medical records of affected patients were reviewed. MAIN OUTCOME MEASURES: Identification of ophthalmic abnormalities.
RESULTS: During the 15-year interval from 1976 through 1990, cutaneous T-cell lymphoma was diagnosed in 2155 patients. Of these, 42 (1.95%; 26 male and 16 female) had at least one ophthalmic abnormality attributable to the disease. The diagnoses in these 42 patients were mycosis fungoides in 19, clinical variants of T-cell lymphoma of the skin (most commonly peripheral T-cell lymphoma) in 11, and Sézary syndrome in 12. Cicatricial eyelid ectropion was the most common finding, affecting 17 (40.4%) of the 42 patients. Thirty-seven patients had findings that, although probably not a direct consequence of cutaneous T-cell lymphoma, have been cataloged in previous studies.
CONCLUSION: Although ophthalmic abnormalities in patients with cutaneous T-cell lymphoma are relatively uncommon, the manifestations of the disease are diverse and frequently difficult to treat.

Entities:  

Mesh:

Year:  1999        PMID: 10406618     DOI: 10.1016/S0161-6420(99)00721-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Peripheral T-cell lymphoma of the eyelid.

Authors:  Hidenori Mito; Hirohiko Kakizaki; Hideki Tsuji; Atsushi Ide; Kengo Takeuchi; Hiroshi Takamura
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

2.  Intraocular involvement of mycosis fungoides associated with immunophenotypic switch from CD4+ to CD8<sup/>.

Authors:  Jonathan A Braue; Anthony B Daniels; Jeffrey P Zwerner; Stephen J Kim; John A Zic
Journal:  Blood       Date:  2018-01-03       Impact factor: 22.113

3.  Ophthalmic disorders in adult lymphoma patients in Africa.

Authors:  Afekhide E Omoti; Caroline E Omoti; Rita O Momoh
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

Review 4.  A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma.

Authors:  Maurilio Ponzoni; Silvia Govi; Giada Licata; Silvia Mappa; Antonio Giordano Resti; Letterio S Politi; Lorenzo Spagnuolo; Eliana Di Cairano; Claudio Doglioni; Andrés J M Ferreri
Journal:  Oncologist       Date:  2013-06-28

5.  Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma: report of a case and review of the literature.

Authors:  Grace A Levy-Clarke; David Greenman; Pamela C Sieving; Gordon Byrnes; Defen Shen; Robert Nussenblatt; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2008 May-Jun       Impact factor: 6.048

6.  Mycosis Fungoides: Uncommon Presentation.

Authors:  Shruti Barnwal; Ravi Kant; Poonam Yadav
Journal:  Int J Appl Basic Med Res       Date:  2021-01-26

7.  Peripheral T-cell lymphoma of the eyelid.

Authors:  Makoto Ishikawa; Hiroshi Watabe; Masahiro Hayakawa; Takeshi Yoshitomi
Journal:  Clin Ophthalmol       Date:  2009-09-24

8.  Corneal infiltration and xanthoma formation in mycosis fungoides.

Authors:  Caleb Busch; Noriyasu Hashida; Kohji Nishida
Journal:  Am J Ophthalmol Case Rep       Date:  2018-06-20

9.  Mycosis Fungoides: Analysis of Ophthalmologic Findings in a Series of Cases.

Authors:  Carina G Colossi; Juliano Mondadori; Pedro K M Barreto; Felipe M Valença; Rodrigo Duquia; Manuel A P Vilela
Journal:  Case Rep Dermatol Med       Date:  2019-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.